8-K
Current Report
Arbutus Biopharma Corp Filed Acc 0001171843-18-000976
Exit or restructuring costs · Regulation FD disclosure
- Item 2.05 Costs associated with exit or disposal activities
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading f8k_020818.htm…